Glaukos Corporation — Quarterly Financial Statistics (NYSE:GKOS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities 507 K-18.52 M6.98 M-10.09 M6.84 M -14.79 M Cash from investing activities 11.79 M-36.95 M-20.78 M-3.99 M-15.89 M -77.61 M Cash from financing activities 60.11 M1.95 M2.25 M5.26 M2.43 M 11.89 M Free cash flow -1.23 M-20.46 M5.8 M-11.72 M3.93 M -22.45 M

뉴스

Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

스티펠, Glaukos에 대한 ’매수’ 등급 재확인

Stifel reiterates Glaukos stock rating on product momentum

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

글라우코스, iDose 및 Epioxa 성장세에 Needham 목표가 상향

Needham raises Glaukos stock price target on iDose, Epioxa growth

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript

Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say

Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

글라우코스, iDose·Epioxa 출시 시점 맞아 실적 발표 예정